Clonal Origin of Pituitary Adenomas*
- 1 December 1990
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 71 (6) , 1427-1433
- https://doi.org/10.1210/jcem-71-6-1427
Abstract
As the pathogenesis of pituitary adenomas remains unclear, the tumor clonal composition of the common neoplasms was studied. Clonality was determined in female patients by analysis of restriction fragment length polymorphisms of the X-chromosome genes hypoxanthine phosphoribosyl transferase and phosphoglycerate kinase in conjunction with their respective methylation patterns. Peripheral lymphocyte DNA was screened from 62 female patients undergoing transsphenoidal surgery for pituitary adenoma. Eleven patients were heterozygous for the BglI site on PGK, 4 for the BamHI site on HPRT, and 1 patient for both sites. Of these 16 patients, 3 had acromegaly, 4 had Cushing''s disease, 7 had hyperprolactinemia, and 2 were clinically nonfunctional. After surgery, morphological study, including immunohistochemistry and electron microscopy of the pathological specimens, allowed a direct comparison between clonality and tumor cell type. Control fresh normal pituitary tissue was found to be polyclonal. The following tumors were monoclonal: all 3 somatotroph adenomas, 4 of 4 lactotroph tumors 3 of 4 corticotroph cell adenomas, a gonadotroph adenoma, and a nonsecretory adenoma. A mixed plurihormonal adenoma was polyclonal, as were 2 tumors consisting of adenomatous lactotrophs interspersed with nontumorous adenohypophyseal pituitary tissue and one corticotroph adenoma mixed with normal pituitary tissue. Functional pituitary adenomas derived from somatotrophs, corticotrophs, or lactotrophs and nonsecretory tumors are monoclonal in nature, suggesting that somatic cell mutations preceed clonal expansion of these cells and play a major role in pituitary tumorigenesis.This publication has 17 references indexed in Scilit:
- Chronic Administration of Corticotropin-Releasing Factor Increases Pituitary Corticotroph Number*Endocrinology, 1987
- Active X chromosome DNA is unmethylated at eight CCGG sites clustered in a guanine-plus-cytosine-rich island at the 5' end of the gene for phosphoglycerate kinase.Molecular and Cellular Biology, 1986
- Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro.Proceedings of the National Academy of Sciences, 1986
- Ectopic Secretion of Corticotropin-Releasing Factor as a Cause of Cushing’s SyndromeNew England Journal of Medicine, 1984
- Differential methylation of hypoxanthine phosphoribosyltransferase genes on active and inactive human X chromosomes.Proceedings of the National Academy of Sciences, 1984
- In VitroStudies on Prolactin Release and Adenylate Cyclase Activity in Human Prolactin-Secreting Pituitary Adenomas. Different Sensitivity of Macro- and Microadenomas to Dopamine and Vasoactive Intestinal Polypeptide*Journal of Clinical Endocrinology & Metabolism, 1983
- Somatotroph HyperplasiaJournal of Clinical Investigation, 1982
- Dopaminergic Receptors in Human Prolactin-Secreting Adenomas: A Quantitative Study*Journal of Clinical Endocrinology & Metabolism, 1980
- Loss of Central Nervous System Component of Dopaminergic Inhibition of Prolactin Secretion in Patients with Prolactin-Secreting Pituitary TumorsJournal of Clinical Investigation, 1978
- Clonal origin of human tumorsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1976